Secondary prevention of ischaemic cardiac events

Overview

Secondary prevention in this context is the long-term treatment to prevent recurrent cardiac morbidity and mortality, and to improve quality of life in people who had either a prior MI or acute coronary syndrome, or who are at high risk of ischaemic cardiac events for other reasons, such as severe coronary artery stenoses or prior coronary surgical procedures.

Latest citations

Platelet function and long-term antiplatelet therapy in women: is there a gender-specificity? A `state-of-the-art` paper. ( 05 August 2014 )

Long-term safety of unopposed estrogen used by women surviving myocardial infarction: 14-year follow-up of the ESPRIT randomised controlled trial. ( 01 May 2014 )